Skip to main content
. Author manuscript; available in PMC: 2015 Dec 15.
Published in final edited form as: Clin Cancer Res. 2014 Oct 21;20(24):6269–6276. doi: 10.1158/1078-0432.CCR-14-1595

Table 3.

Summary of adverse events

Gd 1 Gd 2 Gd 3 Gd 4 Total %
Fatigue 13 3 2 0 18 46
Hypophosphatemia 1 4 3 0 8 21
Hypertension 3 2 2 0 7 18
Transminitis 4 1 0 0 5 13
Hypokalemia 5 0 0 0 5 13
Edema 2 1 0 0 3 8
Hyperglycemia 0 1 2 0 3 8
All grade 3/4 events 23 events in 12 patients (1 grade 4 event; anemia) 31